Conjunctivitis Treatment Market Size is estimated to grow at a CAGR of 5.1% during the forecast period


Posted January 15, 2024 by Jameslin

Conjunctivitis treatment market was valued at USD 4.9 billion globally in 2022, and over the projection period, a compound annual growth rate (CAGR) of 5.1% is anticipated.

 
Conjunctivitis treatment market was valued at USD 4.9 billion globally in 2022, and over the projection period, a compound annual growth rate (CAGR) of 5.1% is anticipated. It is an infection of the membrane that covers the eyeball, and during the rainy season, it affects the conjunctiva. Although it is widely contagious, it rarely has a harmful effect on the human eye. Conjunctivitis caused by allergies is very prevalent and primarily manifests during the hay fever season. The conjunctivitis therapy market encompasses many techniques to controlling this ailment.
Antibiotic eye drops or ointments are frequently used for bacterial conjunctivitis. Antiviral drugs are administered if the conjunctivitis is viral; nevertheless, viral conjunctivitis usually goes away on its own. Lubricating eye drops assist preserve moisture in the eyes and reduce symptoms. It is advised that patients with allergic conjunctivitis use antihistamine eye drops. Steroid eye drops are used to treat patients in severe situations.

Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/conjunctivitis-treatment-market

Growth Drivers
The market for conjunctivitis treatments is expanding as a result of lifestyle modifications and an increase in allergic conjunctivitis cases. The discovery of new medications and treatments through research and development expenditures is another major driver of this market's expansion. The market is expanding because haemorrhagic conjunctivitis is becoming more common.
Partnerships with healthcare professionals and heightened awareness campaigns are two more factors propelling the market's expansion. The market is expanding at a substantial rate due to rising awareness of eye-related disorders.
Segmentation
Drug Class
· Antibiotics
· Antivirals
· Antiallergic
· Artificial Tears
Disease Type
· Bacterial
· Chemical
· Viral
· Allergic Conjunctivitis
Route of Administration
· Oral
· Topical
End-User
· Hospital
· Online Pharmacies
· Retail Pharmacies
Regional Outlook
· Asia Pacific
· North America
· Latin America
· Europe
· Middle East and Africa

Key Players
· Novartis AG
· Cipla Limited
· Abbvie Inc
· Dr. Reddy’s Laboratories limited
· Micro Labs Limited
· Ocular Therapeutix Inc
· Akkorn operating company
· Vitaris Inc
· Aurobindo Pharma Limited
· Other Players

For More Information about this Report @ https://www.xresearch.biz/shop/conjunctivitis-treatment-market

About Us: -
xResearch is a market research and consulting organization that uses unique data, expert analysis, and new technologies to create trusted intelligence on industries. Our research is focused on delivering an informed and impartial view on essential market data of industry, and it is primarily driven by an in-depth study covering the following parameters: Market Sizing and Forecasting, Market Segmentation, Competitive Analysis, Strategic Assessment and Business Modelling.

Contact:
Company Name: xResearch
Contact Person: James Lin
Email: [email protected]
Phone: +1 718-618-4545
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By James
Country United States
Categories Health , Manufacturing , Medical
Tags conjunctivitis treatment market , conjunctivitis treatment market size , conjunctivitis treatment market share , conjunctivitis treatment market news
Last Updated January 15, 2024